These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease. Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486 [TBL] [Abstract][Full Text] [Related]
27. Neuropathological findings in penicillamine-treated patients with Wilson's disease. Horoupian DS; Sternlieb I; Scheinberg IH Clin Neuropathol; 1988; 7(2):62-7. PubMed ID: 3390974 [TBL] [Abstract][Full Text] [Related]
28. [D-penicillamine and collagen]. Camus JP; Koeger AC Ann Biol Clin (Paris); 1986; 44(3):296-9. PubMed ID: 3538948 [TBL] [Abstract][Full Text] [Related]
29. [Effects and adverse effects of D-penicillamine]. Perings E; Junge U Med Klin; 1975 Aug; 70(31):1265-74. PubMed ID: 1107780 [No Abstract] [Full Text] [Related]
30. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine. Borthwick TR; Benson GD; Schugar HJ J Lab Clin Med; 1980 Apr; 95(4):575-80. PubMed ID: 7359013 [TBL] [Abstract][Full Text] [Related]
31. [Long-term D-penicillamine therapy of Wilson's disease in childhood. Changes in blood coagulation and effects on the haematopoetic system]. Hayek HW; Schnack H; Widhalm S Wien Klin Wochenschr; 1973 Feb; 85(8):122-5. PubMed ID: 4632215 [No Abstract] [Full Text] [Related]
32. [Presymptomatic and hepatic forms of Wilson's disease in childhood. Long-term therapy with D-penicillamine]. Kittoe K; Colombo JP Praxis; 1968 Dec; 57(49):1723-9. PubMed ID: 5756864 [No Abstract] [Full Text] [Related]
33. The "lumpy-bumpy" elastic fiber. A marker for long-term administration of penicillamine. Gebhart W; Bardach H Am J Dermatopathol; 1981; 3(1):33-9. PubMed ID: 7235197 [TBL] [Abstract][Full Text] [Related]
34. [Hepatolenticular degeneration treated by Cuprenil Polfa (d-penicillamine)]. Hasik J; Kozal H Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1329-30. PubMed ID: 1161576 [No Abstract] [Full Text] [Related]
35. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine]. Gregersen G; Frederiksen G Ugeskr Laeger; 1971 Jul; 133(29):1406-9. PubMed ID: 5569040 [No Abstract] [Full Text] [Related]
36. [Biochemical bases and therapeutic possibilities of K. Wilson's hepatolenticular degeneration]. Grau-Veciana JM; Barraquer-Bordas L Arch Neurobiol (Madr); 1967; 30(3):251-74. PubMed ID: 4970136 [No Abstract] [Full Text] [Related]
38. A mechanism for the action of penicillamine in the treatment of Wilson's disease. Peisach J; Blumberg WE Mol Pharmacol; 1969 Mar; 5(2):200-9. PubMed ID: 4306792 [No Abstract] [Full Text] [Related]
39. [Penicillamine-induced elastosis perforans serpiginosa and pulmonary cyst in Wilson's disease (author's transl)]. Bardach H; Gebhart W; Niebauer G; Bardach G Wien Klin Wochenschr; 1981 Feb; 93(4):117-22. PubMed ID: 7281683 [TBL] [Abstract][Full Text] [Related]